345 related articles for article (PubMed ID: 24450744)
1. Modulation of the action of insulin by angiotensin-(1-7).
Dominici FP; Burghi V; Muñoz MC; Giani JF
Clin Sci (Lond); 2014 May; 126(9):613-30. PubMed ID: 24450744
[TBL] [Abstract][Full Text] [Related]
2. Counter-regulatory effects played by the ACE - Ang II - AT1 and ACE2 - Ang-(1-7) - Mas axes on the reactive oxygen species-mediated control of vascular function: perspectives to pharmacological approaches in controlling vascular complications.
Pernomian L; Pernomian L; Baraldi Araújo Restini C
Vasa; 2014 Nov; 43(6):404-14. PubMed ID: 25339158
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin-(1-7): beyond the cardio-renal actions.
Passos-Silva DG; Verano-Braga T; Santos RA
Clin Sci (Lond); 2013 Apr; 124(7):443-56. PubMed ID: 23249272
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas axis protects against lung fibrosis by inhibiting the MAPK/NF-κB pathway.
Meng Y; Yu CH; Li W; Li T; Luo W; Huang S; Wu PS; Cai SX; Li X
Am J Respir Cell Mol Biol; 2014 Apr; 50(4):723-36. PubMed ID: 24168260
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic targeting of the angiotensin-converting enzyme 2/Angiotensin-(1-7)/Mas cascade in the renin-angiotensin system: a patent review.
Ferreira AJ; Bader M; Santos RA
Expert Opin Ther Pat; 2012 May; 22(5):567-74. PubMed ID: 22510001
[TBL] [Abstract][Full Text] [Related]
6. The role of the renin-angiotensin system in the development of insulin resistance in skeletal muscle.
Henriksen EJ; Prasannarong M
Mol Cell Endocrinol; 2013 Sep; 378(1-2):15-22. PubMed ID: 22564510
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin-converting enzyme 2, angiotensin-(1-7) and Mas: new players of the renin-angiotensin system.
Santos RA; Ferreira AJ; Verano-Braga T; Bader M
J Endocrinol; 2013 Feb; 216(2):R1-R17. PubMed ID: 23092879
[TBL] [Abstract][Full Text] [Related]
8. Role of renin-angiotensin system in liver diseases: an outline on the potential therapeutic points of intervention.
Ahmadian E; Pennefather PS; Eftekhari A; Heidari R; Eghbal MA
Expert Rev Gastroenterol Hepatol; 2016 Nov; 10(11):1279-1288. PubMed ID: 27352778
[TBL] [Abstract][Full Text] [Related]
9. Captopril improves postresuscitation hemodynamics protective against pulmonary embolism by activating the ACE2/Ang-(1-7)/Mas axis.
Xiao HL; Li CS; Zhao LX; Yang J; Tong N; An L; Liu QT
Naunyn Schmiedebergs Arch Pharmacol; 2016 Nov; 389(11):1159-1169. PubMed ID: 27449068
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin-(1-7) as a strategy in the treatment of hypertension?
van Twist DJ; Kroon AA; de Leeuw PW
Curr Opin Nephrol Hypertens; 2014 Sep; 23(5):480-6. PubMed ID: 25023950
[TBL] [Abstract][Full Text] [Related]
11. Devil and angel in the renin-angiotensin system: ACE-angiotensin II-AT1 receptor axis vs. ACE2-angiotensin-(1-7)-Mas receptor axis.
Iwai M; Horiuchi M
Hypertens Res; 2009 Jul; 32(7):533-6. PubMed ID: 19461648
[TBL] [Abstract][Full Text] [Related]
12. Liver disease and the renin-angiotensin system: recent discoveries and clinical implications.
Lubel JS; Herath CB; Burrell LM; Angus PW
J Gastroenterol Hepatol; 2008 Sep; 23(9):1327-38. PubMed ID: 18557800
[TBL] [Abstract][Full Text] [Related]
13. ACE inhibition, ACE2 and angiotensin-(1-7) axis in kidney and cardiac inflammation and fibrosis.
Simões E Silva AC; Teixeira MM
Pharmacol Res; 2016 May; 107():154-162. PubMed ID: 26995300
[TBL] [Abstract][Full Text] [Related]
14. New insights and perspectives on intrarenal renin-angiotensin system: focus on intracrine/intracellular angiotensin II.
Zhuo JL; Li XC
Peptides; 2011 Jul; 32(7):1551-65. PubMed ID: 21699940
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of ACE2-ANG-(1-7)-Mas axis in jejunal enterocytes of type 1 diabetic rats: implications for glucose transport.
Wong TP; Ho KY; Ng EK; Debnam ES; Leung PS
Am J Physiol Endocrinol Metab; 2012 Sep; 303(5):E669-81. PubMed ID: 22811473
[TBL] [Abstract][Full Text] [Related]
16. Is hypertension in African-descent populations contributed to by an imbalance in the activities of the ACE2/Ang-(1-7)/Mas and the ACE/Ang II/AT
Cohall D; Ojeh N; Ferrario CM; Adams OP; Nunez-Smith M
J Renin Angiotensin Aldosterone Syst; 2020; 21(1):1470320320908186. PubMed ID: 32089050
[TBL] [Abstract][Full Text] [Related]
17. Alamandine: a new member of the angiotensin family.
Villela DC; Passos-Silva DG; Santos RA
Curr Opin Nephrol Hypertens; 2014 Mar; 23(2):130-4. PubMed ID: 24389733
[TBL] [Abstract][Full Text] [Related]
18. The ACE-2/Ang1-7/Mas cascade enhances bone structure and metabolism following angiotensin-II type 1 receptor blockade.
Abuohashish HM; Ahmed MM; Sabry D; Khattab MM; Al-Rejaie SS
Eur J Pharmacol; 2017 Jul; 807():44-55. PubMed ID: 28442323
[TBL] [Abstract][Full Text] [Related]
19. The Anti-Inflammatory Potential of ACE2/Angiotensin-(1-7)/Mas Receptor Axis: Evidence from Basic and Clinical Research.
Rodrigues Prestes TR; Rocha NP; Miranda AS; Teixeira AL; Simoes-E-Silva AC
Curr Drug Targets; 2017; 18(11):1301-1313. PubMed ID: 27469342
[TBL] [Abstract][Full Text] [Related]
20. ACE2, angiotensin-(1–7), and Mas: the other side of the coin.
Bader M
Pflugers Arch; 2013 Jan; 465(1):79-85. PubMed ID: 23463883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]